Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepatorell is a homeopathic medicinal product developed and manufactured by Sanorell Pharma, primarily indicated for the supportive treatment of liver and gallbladder dysfunction. The preparation is a complex of several homeopathic dilutions, incorporating botanical extracts such as *Carduus marianus* (milk thistle), *Chelidonium majus* (greater celandine), and *Taraxacum officinale* (dandelion), alongside organotherapeutic components like *Hepar suis* (porcine liver extract). It is typically formulated as a liquid dilution for injection (subcutaneous, intramuscular, or intravenous). As a homeopathic remedy, its mechanism of action is based on the principle of similitude and the stimulation of the body's self-regulatory processes, rather than direct pharmacological interaction with specific molecular receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hepatorell.